Comoros vs Iraq: Tuberculosis patients living with HIV receiving antiretroviral therapy
Comoros
2 patients
in 2021
Iraq
2 patients
in 2021
Comoros rank
125th
Iraq rank
125th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Comoros
- Iraq
How they compare
Comoros currently reports 2 patients against 2 patients in Iraq, a difference of 0 patients.
The two have swapped places 4 times across 13 shared years of data; in 2006 it was Iraq ahead.
Comoros ranks 125th and Iraq ranks 125th of 183 countries.
Comoros has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Comoros | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 patients | 0 patients | 0 patients | — |
| 2010s | 1.88 patients | 0.25 patients | 1.62 patients | Comoros |
| 2020s | 2 patients | 2 patients | 0 patients | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Comoros or Iraq?
- Comoros, at 2 patients against 2 patients in Iraq as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Comoros and Iraq?
- 0 patients, with Comoros ahead.
- How many years of comparable data are there for Comoros and Iraq?
- 13 years are reported by both, from 2006 to 2021.
- How do Comoros and Iraq rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Comoros ranks 125th and Iraq ranks 125th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.